Sino Biopharmaceutical Limited (HKG: 1177)
Hong Kong
· Delayed Price · Currency is HKD 3.240
+0.020 (0.62%)
Dec 24, 2024, 12:08 PM HKT
Sino Biopharmaceutical Revenue
Sino Biopharmaceutical had revenue of 15.87B CNY in the half year ending June 30, 2024, with 4.48% growth. This brings the company's revenue in the last twelve months to 27.79B, up 8.68% year-over-year. In the year 2023, Sino Biopharmaceutical had annual revenue of 26.20B with 0.67% growth.
Revenue (ttm)
27.79B CNY
Revenue Growth
+8.68%
P/S Ratio
2.00
Revenue / Employee
1.08M CNY
Employees
25,806
Market Cap
58.80B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 26.20B | 173.25M | 0.67% |
| Dec 31, 2022 | 26.03B | -835.19M | -3.11% |
| Dec 31, 2021 | 26.86B | 3.21B | 13.59% |
| Dec 31, 2020 | 23.65B | -586.81M | -2.42% |
| Dec 31, 2019 | 24.23B | 3.35B | 16.02% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSino Biopharmaceutical News
- 3 months ago - Sino Biopharmaceutical Limited goes ex-dividend tomorrow - Seeking Alpha
- 11 months ago - Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln - Reuters
- 4 years ago - Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea - Forbes
- 4 years ago - Week In Review: JD Health Raises $3.5 Billion In Hong Kong IPO, Climbs 56% On First Day - Seeking Alpha